Clinical Trial Update: Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial is evaluating dual-target CAR-NK cell therapy for advanced breast cancer, including HER2-positive and triple-negative subtypes. Recruitment is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Dual-target CAR-NK cell therapy (CAR-NK cells)

Snippet

Sponsor: Beijing Biotech | Conditions: Breast Cancer (Advanced/Metastatic), HER2-positive Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING